Funding · Financial Services

Fundly.ai raises $4.9 million in pre-Series A funding

By Startup Enthusiast · 8 September 2026

What they do

Fundly.ai operates a B2B e-commerce platform, payment infrastructure, and embedded credit services for the Indian pharmaceutical supply chain

The company secured $4 million in equity and $0.9 million in venture debt [loans that do not require equity dilution] from investors

The startup plans to use the capital to scale its commerce, payments, and credit operations across India's pharmaceutical distribution network

Fundly.ai raised $4 million in equity funding during a pre-Series A round.
The round was co-led by Accel and Multiply Ventures.
The company also secured $0.9 million in venture debt from Alteria Capital.
Former RBL Bank executive Rajeev Ahuja and other angel investors participated in the round.
Total funding for the startup has now crossed $7 million.
The company will use the funds to expand its commerce, payments, and credit operations.

The startup aims to digitize the fragmented Indian pharmaceutical supply chain.
It currently serves over 4,100 retailers and 3,000 distributors across multiple cities.
The company is scaling its operations after starting as a supply-chain financing platform.

Fundly.ai provides a B2B e-commerce platform called FundlyMart.
It offers embedded credit [loans integrated directly into the checkout process] for retailers.
The platform provides payment and settlement infrastructure that integrates with distributor ERP systems.
It uses live commerce and payment data to underwrite credit decisions.
The company targets a market of over 70,000 distributors and 1 million retailers.
It plans to launch brand-side programs for manufacturers to access distribution data.

Expand commerce, payments, and credit operations across the pharma supply chain.
Deepen presence in existing cities before entering new geographies.
Scale the transaction and SaaS layer beyond the current Pune pilot.
Build an intelligence layer using trade data.

Accel (lead) — A global venture capital firm.
Multiply Ventures (lead) — An investment firm focused on early-stage startups.
Alteria Capital (participated) — A venture debt provider.

Product: Payment, settlement and commerce infrastructure for pharmaceutical retailers and distributors
Customers: Pharmacy retailers and pharmaceutical distributors across India
How it makes money: B2B fintech providing payments infrastructure, embedded credit and SaaS for pharma supply chain
What sets it apart: ERP integration, supply chain financing and working capital solutions for pharma ecosystem